Patients’ perceptions versus medical testing of function in women with lymphangioleiomyomatosis (LAM)  by Pollock-BarZiv, Stacey M. et al.
ARTICLE IN PRESSRespiratory Medicine (2005) 99, 901–909KEYWORD
Lymphangi
matosis;
Functional
Subjective
0954-6111/$ - s
doi:10.1016/j.r
$This resear
BarZiv, and LAM
Correspondi
University of To
E-mail addrPatients’ perceptions versus medical testing of
function in women with lymphangioleiomyomatosis
(LAM)$
Stacey M. Pollock-BarZiva,b,, Marsha M. Cohenb,c, Heather Macleanb,
Gregory P. Downeyd,eaThe Institute of Medical Sciences, University of Toronto, Canada
bThe Centre for Research in Women’s Health, Sunnybrook & Women’s College Health Sciences Centre,
University of Toronto, Faculty of Medicine, Toronto, Canada
cDepartment of Health Policy, Management and Evaluation, University of Toronto, Canada
dDepartment of Medicine, University of Toronto, Canada
eDivision of Respirology, University Health Network; The Toronto Lung Transplant Program,
R Fraser Elliot Chair in Transplantation Research, Canada
Received 12 May 2004S
oleiomyo-
status;
function
ee front matter & 2005
med.2004.12.005
ch was funded by a Soc
Foundation Grant.
ng author. The Centre
ronto, 790 Bay Street,
ess: s.pollock.barziv@uSummary Lymphangioleiomyomatosis (LAM), a rare pulmonary disease that occurs
primarily in women is characterized by progressive cystic lung lesions causing
respiratory failure, which may require lung transplantation. It has been observed
that in diseases of the lungs, objective medical tests frequently do not translate to
subjective functional status. However, patient’s perceptions of functional status
directly impact quality of life. In order to evaluate this relationship in LAM, a cross
sectional study of 31 lung transplant candidates and 43 lung transplant recipients
with LAM was conducted to evaluate functional status. Objective tests (Pulmonary
function tests, PFTs, 6min walk) were obtained in 19 candidates and 23 recipients,
and subjective function was assessed in all women using the Functional Performance
Inventory. For both groups statistically significant relationships emerged between
forced vital capacity with subjective measures of function including total, social and
recreational function (Po0:05). As well diffusing capacity related significantly to
total function, ability to maintain household chores, body care, and social function
(Po0:05), where higher scores were associated with better subjective function.
Forced expiratory volume in one second was not found to significantly relate toElsevier Ltd. All rights reserved.
ial Sciences and Humanities Research Council of Canada doctoral fellowship to Stacey Pollock-
for Research in Women’s Health; Sunnybrook & Women’s College Health Sciences Centre,
7th floor, Toronto, Ontario, Canada M5G 1N8. Tel.: +1 416 351 3732 2741; fax: +1 416 351 3746.
toronto.ca (S.M. Pollock-BarZiv).
ARTICLE IN PRESS
S.M. Pollock-BarZiv et al.902subjective function in these groups, except the physical exercise domain in
transplant recipients. However, despite better PFT results in double lung transplant
recipients, no differences were found in subjective measures of function between
single and double lung recipients. Results suggest that clinicians need to better
recognize that certain aspects of spirometry/6min walk tests do not necessarily
correlate well with patient’s perceptions of their function. This has implications for
the assessment and follow-up of women living with LAM; considering subjective
aspects of function may help focus interventions and improve quality of life.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Lymphangioleiomyomatosis (LAM) is a rare systemic
lung disease affecting younger women often lead-
ing to debilitating respiratory impairment. There is
no efficacious treatment, variability in its course,
and an unpredictable life expectancy. The patho-
physiology of LAM is characterized by the prolifera-
tion of smooth muscle cells that increasingly invade
lung tissue1–3 leading to decreasing lung function.
Individuals with advanced LAM require supplemen-
tal oxygen and may undergo lung transplantation as
a therapeutic option.4
Functional status is an important clinical mea-
sure of health outcomes and influences one’s
quality of life. It is multidimensional and encom-
passes the ability to perform tasks of daily living,
along with the physical, psychological, and social
capacity to accomplish these tasks.5–7 Moreover,
the ability to perform daily tasks contributes to a
sense of personal value that influences one’s
personal integrity, and is accompanied by a sense
of competence and purpose.5–8 This is particularly
relevant as the perceived experience of function
can ultimately affect quality of life and overall
well-being.5–7,11
Clinicians tend to rely on objective measures of
disease progression and patient functioning. Pul-
monary function tests (PFTs) in LAM typically
demonstrate limitations in air flow (low forced
expiratory volume in one second (FEV1)), decline in
diffusion capacity, and hypoxemia.9,10 In LAM,
despite relatively normal total lung capacity (TLC)
scores, a severe obstructive defect is frequently
observed with elevated residual volume (RV) and
high RV/TLC scores reflecting air trapping.3,9
Exercise performance is invariably impaired with
excessive ventilatory response on formal exercise
testing. Airflow obstruction, impaired diffusing
capacity, exercise capacity and gas exchange
correlate with extent of airway cystic lesions.9,10
Theoretically, PFTs should be good predictors of
severity of disease and with most lung diseases PFTs
are excellent predictors of disease severity (e.g. inchronic obstructive pulmonary disease).8,11 How-
ever, these objective results may not correlate
directly with how patients feel and function in the
world. For example, patients report most concern
about symptoms such as dyspnea which may not be
adequetly reflected in objective tests such as
PFTs.5,8 Moreover, it has been found that dyspnea
is one of the greatest stressors and causes feelings
of ‘ineffectiveness’ in patients with lung dis-
ease.5,12 Further, functional status reflects capacity
and performance; while capacity may not translate
into performance, it reflects the ability to perform,
but not the value such activities may have to the
person.5–8,12 Thus objective medical tests may not
necessarily translate to subjective function—they
may identify deficits in capacity but not the extent
these difficulties will be problematic to the person.
It has been suggested that dyspnea ratings or self-
assessment of functional status along with exercise
tolerance may be better measures of health status
than FEV1, a commonly relied on measure of
pulmonary function, and marker for lung transplant
assessment.8,10,11
In order to bridge the literature regarding
objective and subjective functional status, and to
evaluate the relationship between the two, we
studied function in a group of women with
advanced LAM waiting for a lung transplant and a
group of women with LAM following lung transplan-
tation. We determined whether there were any
relationships between objective medical tests of
pulmonary function and patients’ subjective assess-
ment of their functioning in hopes of providing
additional information to clinicians regarding inter-
preting functional status as experienced by women
with respiratory disease such as LAM.Methods
A cross-sectional research design was carried out in
conjunction with the LAM Foundation located in the
United States. The Foundation is a research funding
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about LAM patients around the world.
Upon receiving institutional research ethics
board approval from the University of Toronto, a
mailed survey was sent to the 46 women wait-listed
and to the 57 transplant recipients registered in the
LAM Foundation database. The survey included a
letter summarizing the study, and subjects were
told that by returning the completed survey to the
LAM Foundation, they were providing informed
consent to participate. The LAM Foundation re-
moved potential identifying information and re-
turned completed surveys to the researchers.
Subjects were also asked to obtain the report of
their most recent pulmonary function (within the
past 6 months) and 6min walk test results from
their pulmonologist or transplant center which
were forwarded to the researchers. Subjects were
given stamped, addressed envelopes to return the
survey and pulmonary function tests results. To
increase the response rate, non-respondents were
mailed a second survey, followed 3 months later by
a postcard reminder.
The survey was designed to elicit demographic
data, time since LAM diagnosis, and use of supple-
mental oxygen. For transplant recipients, we also
ascertained time since transplant, pre and post
transplant utilization of supplemental oxygen, and
whether or not they had been diagnosed with
chronic rejection (bronchiolitis obliterans
syndrome).
As a measure of objective function and disease
severity, pulmonary function tests were used.
These included (actual and percent predicted)
forced expiratory volume in one second (FEV1),
forced vital capacity (FVC), lung volume or total
lung capacity (TLC), residual volume (RV), ratio of
residual volume to total lung capacity (RV/TLC),
and diffusing capacity of lung for carbon monoxide
(DLCO).
As the measure of subjective function, the survey
utilized the Functional Performance Inventory
(FPI).12 The FPI is designed to discriminate across
patients with moderate and severe levels of
perceived severity and activity limitation, and has
been shown to be a reliable and valid indicator of
subjective perceptions of functional performance
in patients with chronic obstructive pulmonary
disease.6,7,12 In addition to assessing overall func-
tional status, the FPI evaluates key domains of
function including physical exercise (e.g., walking
up stairs, short walks around the neighbourhood),
and ability to maintain the household (e.g., grocery
shopping, vacuuming or cleaning). As well, it
assesses body care (e.g., dressing/undressing,
showering), social activities (e.g., helping family/friends, going to the store), and recreational
function (activities for personal pleasure; e.g.,
going to the movies). Scores are reported out of a
maximum of 3, where zero reflects poorest func-
tion, and three represents healthy functioning.
Data analysis
Subject characteristics and background data were
reported descriptively using frequencies, central
tendency, standard error and percentages. For the
transplant candidate and recipient groups, the FPI
results were compared to reports of patients’ most
recent PFTs and 6min walk tests using Pearson’s
correlation coefficients, with P value set at 0.05 (as
has been used in prior research6). Due to the small
sample size, P-values up to P ¼ 0:07 were reported,
to highlight trends that may warrant further study
with larger samples. Results were also compared
for all outcomes between single and double lung
transplant recipients using t-tests with P value set
at 0.05. Data analyses were conducted using SPSS
10.0 statistical software.Results
Transplant candidates
Thirty-one surveys were returned (response rate
67.4%). Of the 31 women who completed the
survey, 19 (61.3%) provided recent PFT data (within
6 months of survey completion). Only respondents
providing objective data were utilized in the
analyses. The mean age was 46.1 years and the
mean number of months on the wait-list was 16.2
(Table 1). Of note, 52% of these women did not
work in the two years prior to transplant due to
reasons reported as ‘disabled’ or ‘retired’, and 26%
were not currently married or with a partner.
Transplant recipients
Forty-three completed surveys were returned of
whom 18 were single lung recipients and 25 double
lung recipients (response rate 75.4%). Of the 43
women who completed the survey, twenty-three
(54%) provided recent PFT data (within 6 months of
survey completion). Only respondents providing
objective data were utilized in the analyses. The
mean age was 45.8 years, and the mean time since
transplant was 4.62 years (Table 1). Seven women
in this group had diagnosed chronic rejection
(bronchiolitis obliterans syndrome) and required
the use of supplemental oxygen; none were listed
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Table 1 Background characteristics of transplant candidates and recipients.
Factor Transplant candidates (n ¼ 31) Transplant recipients (n ¼ 43)
Mean age (yr) (range) 46.1 (30.9–65.5) 45.8 (31.5–60.0)
Mean months listed 16.2 (1.0–60.0) n/a
Mean years post
transplant (range) n/a 4.62 (1.0–11.3)
Marital status n (%) n (%)
K Single 3 (9.7) 11 (25.6)
K Divorced 5 (16.1) 7 (16.3)
K Married/live w partner 23 (74.2) 24 (55.8)
Employment status n (%) n (%)
K Retired or disabled 16 (51.6) 30 (69.8)
K Full-time 6 (19.4) 8 (18.6)
K Part-time 2 ( 6.5) 2 ( 4.7)
K Homemaker 6 (19.4) 3 ( 7.0)
Use supplemental oxygen 29 (93.5) 7 (16.3)
Bronchiolitis obliterans n/a 7 (16.3)
S.M. Pollock-BarZiv et al.904for a retransplant at the time of survey. A higher
percentage of women (70%) of this group noted that
they were not employed since transplant as
compared to the transplant candidates, and 42%
reported being single.PFT Results (Table 2)
Transplant candidates
For transplant candidates, there was a wide range
in the FEV1% predicted scores with values ranging to
below normal up to 72% predicted, and a mean
score of 36.2% predicted. The mean FVC %
predicted was 68.6%, again with wide variability
ranging from 28% predicted to over 100% predicted.
The mean DLCO % predicted was low at 34.9%. For
TLC, high lung volume scores were found across all
patients, with a mean score of 93.6% predicted,
and elevated ratio of RV/TLC, all scores being over
100% predicted. Finally, results of 6-min walk test
result demonstrated markedly low physical ability
with a mean score of 330.2m. The impairment in
pulmonary function was also reflected by the
requirement for supplemental oxygen by 93.5%
women while waiting for their transplant.
In examining the distribution of pulmonary
function results for the candidates, one woman
was found to be an outlier having function results
much better than would be expected for a
transplant candidate (e.g., FEV1 72% predicted,
DLCO 63% predicted). This woman may have been
listed ‘early’ based on center-specific criteria, or
due to long wait-list times. In assessing therelationships between PFTs and FPI scales in the
transplant candidates we ran the analysis using the
PFT data with and without this outlier.Transplant recipients
Following transplant the transplant recipients
showed a wide range of scores for FEV1% predicted
with a mean of 75.8%, mean FVC % predicted was
82.1%, mean DLCO % predicted was 80.9%, and mean
TLC % predicted was 97.8%. The mean 6-min walk
test result was 599.89m, with a wide variability in
distances walked. Post transplant 7/43 (16%)
recipients required the use of some supplemetal
oxygen; these were the women who had been
diagnosed with chronic rejection. Of note, four
women who provided recent PFT/6min walk data,
had diagnosed chronic rejection, and these ac-
counted for the lowest end scores in the spirometry
and 6min walk results.
We reran the analysis of pulmonary function data
by time post transplant after removing the four
patients with BOS, and scores were normally
distibuted (data not presented).
Comparing single and double lung recipient data,
double recipients recipients had demonstrably
better results. SLT recipients represented all
FEV1% predicted scoreso80%. The trend for better
scores was consistent with FVC % predicted, DLCO %
predicted, and 6-min walk test results. In fact,
significant differences were found between single
and double lung recipients for the following
factors: FEV1 actual (t ¼ 6:32; df ¼ 19, Po0:01);
FEV1% predicted (t ¼ 7:84; df ¼ 19, Po0:01). FVC
actual (t ¼ 3:65; df ¼ 19, Po0:01); FVC % predicted
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Table 2 PFT results for transplant candidates and recipients.
Factor Actual (mean) % Predicted (mean) Range % predicted
(I) Transplant candidates (n ¼ 19):
FEV1 0.9 36.9 12.0–72.0
FVC 2.4 67.2 28.0–107.0
TLC 4.8 92.6 60.3–114.0
RV 2.2 126.6 79.3–210.0
RV/TLC 45.4 135.5 102.0–237.0
DLCO 7.7 37.9 22.0–63.0
6min walk 338.65m (range 106.7–510m)
(II) Transplant recipients (n ¼ 23):
FEV1 2.1 75.8 32.9–126.0
FVC 2.8 82.1 31.5–133.0
TLC 5.0 97.8 58.4–122.0
RV/TLC 48.7 102.7 33.0–209.0
DLCO 16.6 80.9 48.0–130.0
6min walk 599.89m (range 400–770m)
Table 3 Functional performance inventory results for transplant candidates & recipients. Scale: 1 ¼ low;
3 ¼ high.
Factor Tx candidates (n ¼ 31) Tx recipients (n ¼ 43)
Mean score (SE) Mean score (SE)
FPI total score 1.6 (0.1) 2.6 (0.1)
FPI physical exercise 1.1 (0.1) 2.7 (0.1)
FPI body care 2.1 (0.1) 2.7 (0.1)
FPI household maintenance 1.5 (0.2) 2.6 (0.1)
FPI social 1.3 (0.2) 2.5 (0.1)
FPI recreational 1.8 (0.2) 2.5 (0.1)
Lung function in LAM 905(t ¼ 4:82; df ¼ 19, Po0:01); DLCO % predicted
(t ¼ 3:04; df ¼ 19, Po0:01), and 6min walk test
(t ¼ 4:31; df ¼ 19, Po0:01).Daily functioning (FPI results)
Transplant candidates
For the wait-listed group, the mean total FPI score
was 1.7, with a wide range in overall function in the
group reported from 0.25 to 2.93 (0 is worst, 3 is
best function). Subjects reported the poorest
performance in the physical exercise domain, while
body care was reported as having the least
difficulty (Table 3).
Transplant recipients
For the group, the mean total post transplant FPI
score was 2.6, with a range of scores in the samplefrom 0.96 to 3.0. Participants reported the highest
performance scores in the physical exercise and
body care domains, while social and recreational
function were reported as slightly lower (Table 3).
There was no statistical differences in FPI scores
between single and double lung recipients on any of
the subscales of FPI (P40:05; data not presented).Relationship between subjective
function (FPI) and objective function
(PFTs)
Transplant candidates
Both FVC and DLCO percent predicted emerged as
having significant positive correlations with the
subjective domains of function on the FPI
(Table 4a). Specifically, for the overall group of
transplant candidates forced vital capacity related
to total function (Po0:05), and domains of physical
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Table 4 Pearson’s correlation coefficients (r) between functional performance inventory scores and PFTresults.
FEV1
% pred
FVC
% pred
TLC
% pred
RV/TLC
% pred
DLCO
% pred
6min walk
(a) For transplant candidates (n ¼ 19)
FPI total 0.32 0.41z 0.13 0.32 0.45 z 0.01
FPI physical exercise 0.29 0.30y 0.30 0.08 0.21 0.01
FPI household maintenance 0.46z 0.39 z 0.23 0.33 0.51 z 0.08
FPI body care 0.55y 0.08 0.07 0.30 0.60 y 0.10
FPI social function 0.24 0.46 z 0.09 0.31 0.44 z 0.05
FPI recreation 0.08 0.36 z 0.09 0.29 0.16 0.41
(b) For transplant recipients (n ¼ 23)
FPI total 0.39 0.58* 0.17 0.26 0.57 z 0.54
FPI physical exercise 0.49 y 0.65* 0.27 0.37 0.56 z 0.45
FPI body care 0.30 0.40y 0.01 0.30 0.54 z 0.21
FPI household maintenance 0.31 0.69* 0.10 0.55 0.59 z 0.53
FPI social function 0.44y 0.60* 0.20 0.46 0.76* 0.67 y
FPI recreation 0.19 0.36* 0.10 0.45 0.21 z 0.10
*Po0:01:
yP ¼ 0:0120:02:
zP ¼ 0:02120:05:
yP ¼ 0:05120:06; all others P40:07:
S.M. Pollock-BarZiv et al.906exercise, household maintenance, social function,
and recreational function. The diffusing capacity
scale correlated significantly with total function
(Po0:05) and domains of household maintenance,
body care, social and recreational function. FEV1
related significnatly to body care and household
maintenance domains of function (Table 4a).
We reran the data without the outlier, and similar
trends were observed with FVC relating to total
function (r ¼ 0:45; Po0:05), social function
(r ¼ 0:50; Po0:05) and recreational function
(r ¼ 0:45; Po0:02), and a trend for approaching
statistically significant relationships with physical
exercise (r ¼ 0:40; P ¼ 0:06) and ability to maintain
the household (r ¼ 0:43; P ¼ 0:056). The diffusing
capacity scale correlated significantly or ap-
proached significance with all domains including
total function (r ¼ 0:67; P ¼ 0:01), household main-
tenance (r ¼ 0:66; P ¼ 0:01), body care (r ¼ 0:54;
P ¼ 0:01), social (r ¼ 0:61; P ¼ 0:04) and recrea-
tional activities (r ¼ 0:52; P ¼ 0:03), and physical
exercise (r ¼ 0:51; P ¼ 0:067). FEV1 related to the
body care domain of function (r ¼ 0:48; Po0:05).
These results confirmed that the relationships
observed held true across the range of physio-
logical values for women with LAM awaiting
transplantation.Pollock-BarZiv, Cohen MM, Maclean H, Downey GP. Relation-
ship between pulmonary function tests and subjective function
in single and double lung transplant recipients with lymphangio-
leiomyomatosis. Abstract presented at the Canadian Society for
Transplantation Annual Meeting, Alberta 2003.Transplant recipients
Significant correlations were found between FVC %
predicted and the DLCO % predicted score for mostsubjective FPI subscale domains (Table 4b), and
FEV1% predicted and the physical exercise domain.
Specifically, FVC related to total function
(P ¼ 0:01), physical exercise (P ¼ 0:06), social
(P ¼ 0:01) and recreational activities (P ¼ 0:01),
while diffusing capacity related to all domains of
subjective function on the FPI (Po0:05). No other
factors on objective tests significantly related to
subjective measures of function for the transplant
recipients.Discussion
Much of the literature investigating function in
pulmonary disease concentrates on predictors of
functional performace such as lung function tests,
exercise capacity, or use of supplemental oxygen.
Moreover, clinicians continue to rely on spirometry
and 6min walk tests in LAM patients despite
increasing evidence that these tests do not relate
well to their actual functional ability in the real
world.10, This study included subjective assess-
ments of function and related these to objective
function. While FEV1 is a commonly relied upon
measure of disease severity in lung disease, in
women with LAM DLCO and FVC emerged as better
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women. Specifically, DLCO and FVC predicted sub-
jective functional status in both transplant candi-
dates and recipients, while FEV1 was found to only
statistically relate to the physical exercise sub-
jective domain in transplant recipients. These
results have important implications for the assess-
ment and follow-up of women with LAM.
The most common symptom complaints of
patients with LAM are dyspnea with exertion,
exercise intolerance, and fatigue, all of which
may impair functional ability. It is well known that
these symptoms are disabling to patients with
chronic lung disease and have considerable impact
on one’s quality of life.5–7,11,14 In our study of LAM
patients, it was demonstrated that there was a
poor correlation between patients’ ratings of
functional impairment and several aspects of their
objective level of impairment measured with
pulmonary function tests. In studies on patients
with COPD and Alpha-1 Antitrypsin deficiency,
patients’ perceptions of functional impairment,
particularly with dyspnea, appeared to be not
associated with objective breathlessness measures,
whereas subjective breathlessness has been shown
to relate to quality of life measures.6,7,11
Women with LAM waiting for a lung transplant
demonstrated a wide range of function, but the
almost total reliance on supplemental oxygen
reflects the generally advanced nature of disease
for this group. Results of objective testing in wait
list candidates reflect a severe obstructive defect
in many patients. The normal total lung capacity
scores, with elevated RV and RV/TLC suggest air
trapping as adequate total volume reserve is
available, suggesting deadspace may be present
thereby limiting physical ability. Reduced FVC
scores are in line with an obstructive defect
common in LAM. Furthermore, findings of the FPI
subjective measure demonstrate markedly reduced
scores on all domains, with lowest scores found for
the physical exercise and social activities sub-
scales.
Intuitively, there should be some relationship
between the extent of pulmonary disability and
subjective ratings of function. Indeed, the statisti-
cally significant relationships that emerged be-
tween certain objective and subjective measures of
function in waitlisted subjects was demonstrated.
FVC and DLCO found to statistically relate with
almost all domains of subjective function, encom-
passing physical, social and recreational aspects.
The finding that FVC relates positively to physical
function after transplant likely reflects the fact
that vital capacity is more dependent on respira-
tory muscle strength and altered chest wallmechanics associated with transplant recovery.13
A decreased FVC, at least partly, may therefore be
explained by the degree of impairment in respira-
tory muscle strength as experienced by the
individual.
No statistically significant relationships emerged
for FEV1 for the transplant candidates, a measure
commonly relied upon as a marker of disease
severity in other pulmonary diseases such as
emphysema, and frequently used as a decisive
factor for wait-listing for a lung transplant. This is
interesting in light of literature in LAM that
suggests that while diffusing capacity and FEV1
are both decreased, the decrease is not in parallel
to one another, thereby complicating the use of PFT
measures in assessing disease severity and progres-
sion.10 Furthermore, the TLC score prior to and
following transplant was not found to relate to
subjective functional status, despite the percep-
tion that lung volume should theoretically corre-
spond with apparent function.8,13 One would
expect that the 6min walk results would related
to the FPI total score, and physical exercise
domain. One would expect that the 6-min walk
results would relate to the FPI total score, and
physical exercise domain. However, 6-min walk test
results are not well reproducible and this test has
not been proven to be clinically practical for
determining functional capacity.14 A recent study
correlated objectve functional measures (PFTs and
exercise testing) with disease severity on high
resolution CT and found that cardiopulmonary
exercise testing predicts disease severity and the
need for supplemental oxygen in LAM patients.10
However, they point out that abnormalities in DLCO
and FEV1 (reflecting severity of impairment and
rate of decline) do not parallel eachother; while
the functional limitation in some patients was
limited to ventialtory problems due to airflow
obstruction, other patients have almost exclusively
impairments in DLCO with well preserved flow
rates.10 They therefore question the utility of
standard measures of function, and argue for the
need for cardiopulmonary exercise testing to
better delineate the functional impairment. Simi-
larly, we speculate that the broad range in results
for the 6min walk test observed, along with the
small sample size, reduced the ability to find
statistically significant relationships between some
objective and subjective measures of functional
performance. Larger prosepective studies are
needed to further clarify these relationships.
Functional scores in the post transplant group
reflected good overall function on both objective
and subjective measures. In addition to improved
respiratory function measures as compared to the
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also observed by the reduction in post transplant
supplemental oxygen utilization. It has been
reported that improved pulmonary function peaks
within 3–6 months after transplant as the chest
wall mechanics recover and pain and tissue trauma
associated with the transplant surgery start to
subside.13 This is also in keeping with the finding
that arterial oxygenation rapidly returns to normal
levels following uncomplicated lung transplanta-
tion.13
Interestingly, despite better PFT results in double
lung transplant recipients, no differences were
found in subjective measures of function between
single and double lung recipients. There is some
debate about the need to transplant single versus
double lungs. In Canada, the ideal is double lung
and some centers are reluctant to perform single
lung transplants. In the United States, this decision
varies with transplant center and other factors such
as allocation issues. It is noteworthy that although
those who have had a double lung transplant
perform better on objective medical tests, those
who received single lung transplants perceive their
functional status as equally good. These results
warrant further prospective study to better under-
stand the underlying subjective aspects of this
difference.
Results of our study are limited in the observa-
tional nature of the study. It is possible that non-
respondents may have different experiences than
the respondents. This study did not follow the same
group of patients pre and post transplant i.e. the
group of transplant candidates were not the same
women as the group of transplant recipients. While
there were a relatively small number of subjects
per group, potentially limiting our ability to find
statistically significant differences (due to low
power), this remains the largest homogeneous
group of LAM patients studied addressing function.
Groups were similar and from a wide variety of
backgrounds thus increasing the generalizability of
the results. Additionally, results were obtained at a
single time point that varied for each patient and
we recognize that outcomes may vary over time
both for the transplant candidates and transplant
recipients. Prospective studies are justified to
further elucidate the factors that predict func-
tional outcomes, with particular emphasis on the
subjective experiences of function while waiting
for and following lung transplantation. Moreover,
studies are currently underway to ascertain the
impact of functional status on quality of life and
well-being prior to and after transplant.
Much of the literature investigating function in
pulmonary disease concentrates on predictors offunctional performance such as lung function tests,
exercise capacity, or use of supplemental oxygen.
The present study included subjective assessments
of pulmonary function in various domains and
related these measures to objective function.
These findings offer insight into the functional
status of women with LAM, both who are waiting for
a transplant and who have undergone lung trans-
plantation. The ability to function is multidime-
sional and is associated with maintaining a sense of
personal integrity.5–8,12 This is particularly relevant
as the perceived experience of function can
ultimately affect quality of life and well-being.
Therefore, the emergence of relationships between
certain objective and subjective measures of
function in both groups offer insights into the
functional experience of women with LAM.
In conclusion, measuring functional status is
important. Using the FPI, we found significant
relationships between perceived functional state
prior to and following transplantation for LAM.
These results have implications for the clinical
measurement of pulmonary function and poten-
tially for enhancing outcomes while waiting for a
transplant and following transplant. Using both
subjective and objective measures of function
may help better delineate practical functional
outcomes as they relate to one’s ability to function
in the real world. Results could provide val-
uable information to clinicians trying to define
and enhance the quality of life of patients with
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